Vertex In The Vortex: More Cash, A Bigger Loss And The Departure Of A Key Executive
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug maker sells future milestone payments for its Hepatitis C drug, but loses its chief commercial officer and head of strategic development.